These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1827031)

  • 1. Primary systemic therapy for operable breast cancer.
    Anderson ED; Forrest AP; Hawkins RA; Anderson TJ; Leonard RC; Chetty U
    Br J Cancer; 1991 Apr; 63(4):561-6. PubMed ID: 1827031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
    Anderson ED; Forrest AP; Levack PA; Chetty U; Hawkins RA
    Br J Cancer; 1989 Aug; 60(2):223-6. PubMed ID: 2527549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
    Cameron DA; Anderson ED; Levack P; Hawkins RA; Anderson TJ; Leonard RC; Forrest AP; Chetty U
    Br J Cancer; 1997; 76(8):1099-105. PubMed ID: 9376273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study).
    Gazet JC; Ford HT; Coombes RC
    Br J Cancer; 1991 Feb; 63(2):279-82. PubMed ID: 1825469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology.
    von Matthiessen H; Distler W
    Recent Results Cancer Res; 1990; 118():190-5. PubMed ID: 2146725
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
    Stein RC; Dowsett M; Hedley A; Gazet JC; Ford HT; Coombes RC
    Br J Cancer; 1990 Oct; 62(4):679-83. PubMed ID: 2145964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.
    Gazet JC; Coombes RC; Ford HT; Griffin M; Corbishley C; Makinde V; Lowndes S; Quilliam J; Sutcliffe R
    Br J Cancer; 1996 Mar; 73(6):758-62. PubMed ID: 8611376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.
    Dowsett M; Stein RC; Coombes RC
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):155-9. PubMed ID: 1388047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients.
    Lien EA; Johannessen DC; Aakvaag A; Lønning PE
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):541-3. PubMed ID: 1532904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.
    Powles TJ; Hickish TF; Makris A; Ashley SE; O'Brien ME; Tidy VA; Casey S; Nash AG; Sacks N; Cosgrove D
    J Clin Oncol; 1995 Mar; 13(3):547-52. PubMed ID: 7884414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.
    Masuda N; Sagara Y; Kinoshita T; Iwata H; Nakamura S; Yanagita Y; Nishimura R; Iwase H; Kamigaki S; Takei H; Noguchi S
    Lancet Oncol; 2012 Apr; 13(4):345-52. PubMed ID: 22265697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer.
    Murray R; Pitt P
    Breast Cancer Res Treat; 1995 Sep; 35(3):249-53. PubMed ID: 7579495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
    Friedrichs K; Jänicke F
    Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
    Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
    Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.
    Michaud LB; Buzdar AU
    Drugs Aging; 2000 Apr; 16(4):261-71. PubMed ID: 10874521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aromatase inhibitors].
    Mauriac L; Bonneterre J
    Bull Cancer; 2000 Dec; 87 Spec No():5. PubMed ID: 11250603
    [No Abstract]   [Full Text] [Related]  

  • 18. Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?
    Hawkins RA; Tesdale AL; Anderson ED; Levack PA; Chetty U; Forrest AP
    Br J Cancer; 1990 Jun; 61(6):877-80. PubMed ID: 2372489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
    Holdaway IM
    Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New trends in the endocrine treatment of breast cancer.
    Maass H; Jonat W; Eidtmann H; Kunz T; Kügler G
    Recent Results Cancer Res; 1990; 118():225-32. PubMed ID: 2146726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.